49 filings
Page 2 of 3
8-K
72ry5iz
14 Nov 22
Gelesis Reports Third Quarter 2022 Results
8:56am
8-K
c6ftu0 lwhc4oj
4 Nov 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:02pm
8-K
ul2 nbb4g2hd
3 Oct 22
Departure of Directors or Certain Officers
8:41am
8-K
blev0mblq3g98lgx47e
15 Aug 22
Gelesis Reports Second Quarter 2022 Results
7:01am
8-K
zwwdr4v9mfds3cms
12 Aug 22
Entry into a Material Definitive Agreement
4:02pm
8-K
2x8e8giunwdyktsxhvk
10 Aug 22
Entry into a Material Definitive Agreement
4:48pm
8-K
oovj6br1x0piz
29 Jul 22
Entry into a Material Definitive Agreement
4:01pm
8-K
b8wvlrsq4ncfwkkq 0n
21 Jun 22
Gelesis Announces Additional $15 Million Pre-Order for Plenity®, Bringing Total Pre-Paid Orders from Ro for Plenity to $55 Million
6:30am
8-K
f8caw bnigv5iboa
12 May 22
Results of Operations and Financial Condition
4:01pm
8-K
c8kux8 qz6owywb
10 May 22
Changes in Registrant's Certifying Accountant
4:39pm
8-K/A
kdc1ib2oan8eamy98q0r
1 Apr 22
Financial Statements and Exhibits
5:08pm
8-K/A
x2bvhfliu shv
24 Mar 22
Financial Statements and Exhibits
4:08pm
8-K
22ta3afz7p7rq17
24 Mar 22
Gelesis® Reports Fiscal Year 2021 Results and Fiscal Year 2022 Financial Outlook
4:06pm
8-K
jfxa39
16 Mar 22
New Plenity patient prescriptions increased 3.5-fold within the first three weeks of the national media campaign launch
6:31am
8-K
xmgv186j mb
31 Jan 22
Other Events
6:48am
8-K
9weqt
20 Jan 22
Proceeds from this transaction will be used to further support the national launch of Plenity
5:24pm
8-K
obgqtf
12 Jan 22
Submission of Matters to a Vote of Security Holders
4:09pm
8-K
aj96mind ryqsidi8fpm
10 Jan 22
Other Events
6:25am
8-K
g4wpjts2bd
3 Jan 22
Entry into a Material Definitive Agreement
7:01am
8-K
aoerx9wurfay
13 Dec 21
Departure of Directors or Certain Officers
9:49pm